Eudragit S100 coated iron oxide-chitosan nanocomposites for colon targeting of 5-aminosalicylic acid ameliorate ulcerative colitis by improving intestinal barrier function and inhibiting NLRP3 inflammasome
-
Published:2024-09
Issue:
Volume:139
Page:112661
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Zhang Dandan,
Wan Hao,
Zhao Ran,
Zhang Yu,
Chen HongORCID
Reference70 articles.
1. Third european-evidence-based consensus on diagnosis and management of ulcerative colitis. part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders;Magro;J Crohns Colitis.,2017
2. Ulcerative colitis: an update;Segal;Clin Med.,2021
3. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies;Ng;Lancet,2017
4. Fecal microbial dysbiosis in chinese patients with inflammatory bowel disease;Ma;World J of Gastroenterol.,2018
5. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences;Loftus;Gastroenterology,2004